This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Senior Vice President of Medical Affairs and Innovation at Orchestra BioMed. This could provide a new paradigm for the treatment of hypertension and its many associated risks in pacemaker-indicated patients and other higher risk populations, offering the opportunity to potentially intervene earlier in disease progression.
Since its introduction, numerous innovations have been made and clinical experience was gained leading to its adoption in current practice and preference in certain populations. Moreover, emerging technologies like the extravascular ICD or the combination of the S-ICD with the leadless pacemaker offer new possibilities for the future.
Even with success accomplished through extensive propagation of advanced technologies, there is substantial opportunity to advance medical techniques. Discussing further, Catheterization Laboratory, also called Cath Lab, is a medical examination room where angiogram, angioplasty, ablation, and implantation of pacemaker are carried out.
History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technologicalinnovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.
Advancements in medical technology have revolutionized the diagnosis and treatment of heart diseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. Startups are developing image analytics solutions using deep learning technologies to improve patient outcomes.
Cardiology is an evolving field, and staying ahead with the latest technological advancements is paramount in delivering efficient, top-notch care. Embracing and implementing cutting-edge technologies allows cardiologists to provide the highest quality care and stay at the forefront of medical advancements.
We hope that the anniversary contributions will help to support the college's mission and mission-focused work that empowers future leaders in the next generation of cardiovascular innovators through scholarship, mentorship and leadership development programs. “We There are 11 learning pathways during this year's meeting.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content